Fitbit Sense 2: Continuous Stress Monitoring With ECG and Electrodermal Activity at an Accessible Price

The only mainstream smartwatch combining FDA cleared ECG with continuous electrodermal activity sensing, Fitbit Sense 2 brings clinical grade heart rhythm screening and real time stress biology monitoring to a sub $250 price point.

Presented By Our Partners

Chronic psychological stress does not stay psychological. It rewires the body. Sustained elevation of cortisol and adrenaline suppresses immune function, accelerates arterial plaque formation, disrupts blood glucose regulation, and reshapes the brain’s prefrontal cortex and hippocampus in ways that impair memory and decision making. A 2017 study published in The Lancet by Tawakol et al. demonstrated, for the first time using brain imaging, that heightened activity in the amygdala (the brain’s stress processing center) directly predicted subsequent cardiovascular events. Among 293 participants followed for a median of 3.7 years, those with the highest amygdalar activity had significantly greater risk of heart attack and stroke, independent of traditional risk factors like cholesterol and blood pressure.

The connection between chronic stress and cardiovascular disease is no longer speculative. It is mechanistic. Stress activates the sympathetic nervous system, which increases heart rate, reduces heart rate variability, triggers systemic inflammation, and promotes the development of atherosclerosis. The broader medical research community now recognizes chronic stress as an independent risk factor for cardiovascular disease, the first of the Four Villains that threaten human healthspan.

The challenge is measurement. Unlike blood pressure or cholesterol, stress has no single number. It is a complex physiological state involving the autonomic nervous system, the hypothalamic pituitary adrenal (HPA) axis, and the immune system simultaneously. But one biomarker has emerged as a particularly sensitive, non invasive window into sympathetic nervous system activation: electrodermal activity (EDA). The Fitbit Sense 2 is currently the only mainstream smartwatch that combines continuous EDA monitoring with FDA cleared ECG and irregular heart rhythm notifications, bringing stress biology and cardiac screening together in a single $249.95 device.

What Is the Fitbit Sense 2?

The Fitbit Sense 2 is Google’s (Fitbit’s) advanced health focused smartwatch, positioned as the most sensor rich device in the Fitbit lineup. The 40.5mm aluminum case houses an AMOLED display and Fitbit’s most comprehensive biosensor array, including optical heart rate and HRV monitoring, an electrical sensor for on demand ECG recording, SpO2 (blood oxygen) tracking, skin temperature sensing, and a continuous electrodermal activity (cEDA) sensor that measures sympathetic nervous system activation throughout the day.

The cEDA sensor is the Sense 2’s signature feature. Unlike the original Fitbit Sense, which required users to place their palm over the screen for a spot check EDA reading, the Sense 2 monitors electrodermal activity continuously and passively. When the sensor detects a significant shift in sympathetic arousal, the watch delivers a Body Response notification, prompting the user to log what they were doing and how they felt. Over time, this creates a map of stress triggers and patterns that would be invisible without continuous physiological monitoring.

Additional features include FDA cleared ECG for atrial fibrillation detection, FDA cleared irregular heart rhythm notifications (IHRN), sleep staging with sleep score, estimated VO2 max (cardio fitness score), and the Daily Readiness Score (available with Fitbit Premium subscription). The watch retails at $249.95 with an optional Fitbit Premium subscription at $9.99/month or $79.99/year that unlocks advanced analytics including stress management insights, sleep profiles, and wellness reports.

The Science Behind It: Electrodermal Activity, Stress, and Cardiovascular Risk

Electrodermal activity measures changes in the electrical conductance of the skin, which fluctuates based on sweat gland activity controlled by the sympathetic nervous system. When the sympathetic system activates (during stress, anxiety, excitement, or physical exertion), eccrine sweat glands increase their output, raising skin conductance. This response is involuntary and virtually impossible to consciously suppress, making EDA one of the most objective, non invasive markers of sympathetic arousal available.

According to PubMed, a 2023 systematic literature review published in the International Journal of Medical Informatics by Vos et al. analyzed the current state of machine learning enabled stress monitoring from wearable devices. The review identified electrodermal activity, heart rate variability, and heart rate as the primary biomarkers correlated with elevated stress, noting that EDA is “a highly sensitive, accurate and non invasive measure of the sympathetic nervous system’s activity.” The review found that while laboratory grade EDA devices are well validated, consumer wearable EDA monitoring is still maturing, with generalization of stress detection models requiring further research (DOI).

According to PubMed, a 2021 study published at the IEEE Engineering in Medicine and Biology Society Conference by McNaboe et al. validated spectral indices of electrodermal activity from a wearable device against a laboratory grade reference device in 18 subjects undergoing orthostatic and cognitive stress tests. The researchers found that frequency domain EDA indices performed comparably between the wearable and reference devices, supporting the feasibility of obtaining clinically meaningful EDA measurements from wrist worn consumer hardware (DOI).

The link between chronic stress (as reflected in sustained sympathetic activation) and cardiovascular disease is well established. Chronic sympathetic overdrive increases resting heart rate, reduces heart rate variability, promotes systemic inflammation, and accelerates atherosclerosis. The European Society of Cardiology’s 1996 guidelines on HRV established that reduced heart rate variability, a direct consequence of chronic sympathetic dominance, is independently associated with increased cardiac mortality.

ECG monitoring adds a complementary screening dimension. The BASEL Wearable Study (2023, JACC: Clinical Electrophysiology, Mannhart et al.) demonstrated that consumer smartwatch ECG recordings achieve sensitivity exceeding 90% for atrial fibrillation detection, validating the clinical utility of the single lead ECG technology that the Fitbit Sense 2 employs.

That is the science. Here is how the Fitbit Sense 2 applies it.

What the Fitbit Sense 2 Does Well

The Sense 2’s continuous EDA monitoring is genuinely unique in the mainstream smartwatch market. No other device at this price point, and very few at any price, offers passive, all day electrodermal activity tracking that alerts users to physiological stress responses in real time. The Body Response notification system transforms EDA data from an abstract scientific concept into actionable awareness: “Your body just had a significant stress response. What were you doing? How did you feel?”

Over weeks and months, the pattern of logged Body Responses creates a personalized stress map that can reveal triggers the user may not consciously recognize: specific meetings, commute times, dietary choices, sleep deprivation effects, or social situations that reliably activate the sympathetic nervous system. This kind of longitudinal stress awareness has historically been available only through clinical psychophysiology research or intensive therapeutic self monitoring.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

The FDA cleared ECG and irregular heart rhythm notification system bring cardiac screening to a price point that makes it accessible to a much wider population than premium competitors. At $249.95, the Sense 2 is the most affordable FDA cleared ECG smartwatch available, significantly less than the Apple Watch Series 9 ($399), Samsung Galaxy Watch 7 ($299.99), or any Garmin device with ECG ($999.99).

Sleep tracking on the Sense 2 provides detailed sleep staging (light, deep, REM), a nightly sleep score, skin temperature trends (useful for menstrual cycle tracking), and SpO2 monitoring. The Fitbit sleep algorithm benefits from over a decade of consumer sleep data and has been validated in multiple peer reviewed studies showing reasonable agreement with polysomnography for sleep staging.

Pricing, Access, and Practical Realities

The Fitbit Sense 2 retails at $249.95. Fitbit Premium, which unlocks advanced features including Daily Readiness Score, stress management insights, detailed sleep profiles, and guided wellness programs, costs $9.99/month or $79.99/year. First year total cost of ownership is $249.95 without Premium or $329.94 with the annual Premium subscription.

This pricing positions the Sense 2 as the most accessible FDA cleared ECG smartwatch on the market. For comparison, the Apple Watch Series 9 starts at $399 (plus iPhone required), the Samsung Galaxy Watch 7 starts at $299.99 (plus Galaxy phone required for full features), and the Oura Ring Gen 3 costs $299 to $499 plus $69.99/year for membership.

The Sense 2 works with both iOS and Android smartphones via the Fitbit app. All FDA cleared features (ECG, irregular heart rhythm notifications) function on both platforms, an important distinction from Samsung’s Android exclusivity for clinical features. However, the Fitbit app’s analytics depth is now more limited than it was before the Google acquisition, and some previously free features have been moved behind the Premium paywall.

Regarding regulatory status: the Sense 2 carries FDA clearance for ECG (atrial fibrillation detection and normal sinus rhythm classification) and FDA clearance for irregular heart rhythm notifications. The cEDA sensor, stress monitoring, sleep staging, and VO2 max estimation are classified as general wellness features without FDA clearance. The EDA based stress monitoring should not be used as a diagnostic tool for anxiety disorders or other clinical conditions.

Who the Fitbit Sense 2 Is Best For

The Sense 2 is ideal for health conscious consumers who want stress awareness and cardiac screening without the complexity or cost of premium fitness watches. It is particularly well suited for individuals who experience work related stress, anxiety, or burnout and want objective physiological data about their stress patterns. It also serves women tracking menstrual cycles through skin temperature trends, adults over 40 who want affordable AF screening, and anyone who prioritizes sleep quality improvement and wants detailed, validated sleep analytics.

Budget conscious consumers who want FDA cleared ECG at the lowest available price will find the Sense 2 difficult to beat. The device delivers clinical cardiac screening and continuous stress monitoring for less than the cost of a single cardiology office visit in most US markets.

Who may want to skip it: serious athletes and endurance sports enthusiasts will find the Sense 2’s training analytics shallow compared to Garmin or Apple Watch. There is no VO2 max trending, no training load analysis, no running dynamics, and no built in GPS (the Sense 2 uses connected GPS via the paired smartphone). Users who want a premium smartwatch experience with app ecosystem depth should consider Apple Watch. Anyone who wants the most complete health monitoring without a subscription will find that the Sense 2 gates too many features behind Fitbit Premium to deliver its full value at the $249.95 base price.

How It Compares

Against the Apple Watch Series 9 ($399 to $499), the Sense 2 saves $150 or more while offering unique continuous EDA stress monitoring that Apple does not provide. Apple counters with a larger app ecosystem, cellular connectivity, crash detection, deeper fitness tracking, and a more premium build quality. Apple also provides more detailed cardio fitness (VO2 max) tracking and walking steadiness measurements that the Sense 2 lacks. For stress focused health monitoring at a budget, Fitbit wins. For overall smartwatch capability, Apple wins.

Compared to the Samsung Galaxy Watch 7 ($299.99), the Sense 2 is $50 less expensive and offers continuous EDA monitoring that Samsung does not include. Samsung provides more advanced fitness tracking, a brighter display, and Samsung Health integration. Both offer FDA cleared ECG. Samsung requires a Galaxy phone for full features; Fitbit works on both platforms. For stress biology monitoring, the Sense 2 is the stronger choice.

Against the WHOOP 4.0 ($239/year subscription), the Sense 2 provides a screen, ECG, and EDA monitoring that WHOOP lacks, at a lower first year cost. WHOOP offers more sophisticated strain and recovery analytics and a smaller, more comfortable form factor. For users who want a display, cardiac screening, and stress awareness, the Sense 2 offers more functionality. For dedicated recovery optimization without a screen, WHOOP is more focused.

Limitations and Open Questions

The most significant criticism of the Fitbit Sense 2 is the Fitbit Premium paywall. Features that feel essential to the device’s value proposition, including Daily Readiness Score, detailed stress management insights, and sleep profiles, require a $79.99/year subscription. Without Premium, the Sense 2 delivers considerably less analytical depth than competitors that include all features with the hardware purchase.

The continuous EDA sensor, while scientifically grounded, produces data that is less clinically validated than ECG or HRV for predicting health outcomes. EDA responds to any sympathetic activation, including positive excitement, physical exertion, and temperature changes, not just negative stress. Users must learn to contextualize Body Response notifications, understanding that a spike during an exciting phone call is physiologically similar to a spike during a stressful meeting.

The absence of built in GPS is a practical limitation for runners and walkers who want accurate distance and pace tracking without carrying their phone. This omission positions the Sense 2 as a health monitor rather than a fitness watch, which may frustrate users expecting smartwatch level athletic functionality at this price point.

Fitbit’s future under Google’s ownership remains an open question. Google has integrated Fitbit hardware into its Pixel ecosystem and has moved some Fitbit features to the Google Pixel Watch line. Long term software support, feature development, and the trajectory of Fitbit Premium are uncertain.

What This Means for Your Health

Stress is not the fifth pillar of Healthcare Discovery‘s longevity framework. It is the silent amplifier that weakens all five. Chronic stress disrupts sleep architecture, degrades nutritional choices, reduces exercise motivation, suppresses the parasympathetic recovery that breathwork cultivates, and erodes the cognitive resilience that Mindset provides. It is the background noise that makes every other health intervention less effective.

The Fitbit Sense 2 makes stress visible. The continuous EDA sensor does not diagnose anxiety or prescribe treatment. It does something more fundamental: it provides objective, real time evidence of your body’s sympathetic activation patterns. For many people, simply seeing a Body Response notification after a difficult meeting, a skipped meal, or a night of poor sleep creates a feedback loop that drives better choices.

The FDA cleared ECG adds a cardiovascular screening layer that addresses the first of the Four Villains directly. Atrial fibrillation, often asymptomatic and frequently triggered or worsened by chronic stress, is the leading arrhythmic cause of stroke. Having both a stress awareness tool and a cardiac rhythm screening tool on the same wrist creates a monitoring ecosystem that captures the relationship between daily stress patterns and cardiac health.

At $249.95, the Sense 2 removes the cost barrier that keeps most people from accessing this level of physiological self awareness. It is not the most powerful wearable available. It is not the most accurate. But it may be the most democratizing: a device that brings stress biology monitoring and FDA cleared cardiac screening to a price point accessible to the population that needs it most. Pair it with the fundamentals: consistent sleep schedules, daily movement, nutrient dense whole foods, and regular breathwork or meditation practice. The Sense 2 shows you the physiological impact of those choices. The choices themselves are still yours to make.

Frequently Asked Questions

What is the Fitbit Sense 2 cEDA sensor?
The continuous electrodermal activity (cEDA) sensor measures changes in skin conductance caused by sympathetic nervous system activation. Unlike the original Sense, which required manual EDA readings, the Sense 2 monitors EDA passively throughout the day and sends Body Response notifications when significant sympathetic arousal is detected. A 2023 systematic review in the International Journal of Medical Informatics identified EDA as “a highly sensitive, accurate and non invasive measure of the sympathetic nervous system’s activity.”

Does the Fitbit Sense 2 have ECG?
Yes. The Sense 2 includes an FDA cleared ECG function that detects atrial fibrillation and classifies normal sinus rhythm. Users open the ECG app and place a finger on the stainless steel bezel to record a 30 second single lead ECG. Results are stored in the Fitbit app and can be exported as PDFs for physician review. At $249.95, it is the most affordable FDA cleared ECG smartwatch available.

Is Fitbit Premium worth it for the Sense 2?
Fitbit Premium ($9.99/month or $79.99/year) unlocks Daily Readiness Score, detailed stress management insights, sleep profiles, and guided wellness programs. Without Premium, the Sense 2 still provides ECG, continuous EDA monitoring, sleep staging, heart rate tracking, and Body Response notifications. Whether Premium is worth it depends on how deeply you want to analyze your data. Users who want comparable depth without a subscription should consider the Garmin Venu 3, which includes all analytics features in the purchase price.

Does the Fitbit Sense 2 have GPS?
No. The Sense 2 uses connected GPS, meaning it relies on your paired smartphone’s GPS for location tracking during outdoor activities. This adds phone dependency for accurate distance, pace, and route mapping during walks and runs. Users who need built in GPS should consider the Google Pixel Watch 2 or Apple Watch Series 9.

How accurate is Fitbit Sense 2 sleep tracking?
Fitbit’s sleep staging algorithm has been validated in multiple peer reviewed studies showing reasonable agreement with polysomnography for classifying light, deep, and REM sleep stages. A 2021 validation study found Fitbit’s sleep staging accuracy comparable to other consumer wearables, with the strongest agreement for total sleep time and the weakest for deep sleep classification. The Sense 2 also tracks skin temperature and SpO2 during sleep, adding contextual data for sleep quality assessment.

Can the Fitbit Sense 2 detect stress?
The Sense 2’s cEDA sensor detects sympathetic nervous system activation, which occurs during both positive and negative stress. It sends Body Response notifications when significant physiological arousal is detected, prompting you to log the context. Over time, this creates a pattern map of stress triggers. However, the device cannot distinguish between positive excitement, physical exertion, and psychological distress. It measures the body’s arousal response, not the emotional quality of the experience. The feature is classified as general wellness and is not FDA cleared for diagnosing anxiety or stress disorders.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.